EKF Diagnostics Holdings plc (LON:EKF – Get Free Report) shot up 0.8% during mid-day trading on Wednesday . The company traded as high as GBX 25.51 ($0.33) and last traded at GBX 25 ($0.32). 4,511,308 shares changed hands during mid-day trading, an increase of 1,017% from the average session volume of 403,962 shares. The stock had previously closed at GBX 24.80 ($0.32).
EKF Diagnostics Stock Performance
The company has a quick ratio of 1.77, a current ratio of 4.59 and a debt-to-equity ratio of 1.78. The firm has a 50 day moving average of GBX 27.11 and a 200-day moving average of GBX 28.24. The company has a market cap of £109.80 million, a P/E ratio of 2,500.00 and a beta of 0.57.
EKF Diagnostics Company Profile
EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.
Read More
- Five stocks we like better than EKF Diagnostics
- How to Invest in Small Cap Stocks
- The Great CPU Race: AMD and Intel Battle for Dominance
- ESG Stocks, What Investors Should Know
- GameStop Turns a Profit: So What? It’s Still Not Worth Investing
- Why Are Stock Sectors Important to Successful Investing?
- C3.ai Stock Surges on Strong Sales Despite Profit Concerns
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
